CarciÌroma o{ thg utorlne ceryix ls one ol tho highest couses of mortallly in lemqle c{nccr pttients worldwide,ìnd improved treotúent options for this type of molign4ncy are highly necded. Local hl,poÍhetmia hoa been cucccsafultv uscd ir comblnation rÀ,lth oystemlc &dministraflon of cisplatin_basod chemotherapy in phase I/II clinical studiod. Hoat_inducerl oxpression of cytdrrofecdve and andqmptotic heat shock pmteiÍs (HSP) is o knoivn compllcation of hylrertherrnia, resulting in tlîormgtoloranco and chemoresietonce ond hlndering thg olîcacy of the combination tholopy. Heat shock l.aaEecrlptlon factof I (HSFI) ie ahe ma8teÌ regulator of heat_ lnduccd HSp cxprossiorì. In the prcsenl report, we used smsll inlarfering RNA (siRNA) 10 silcnce HSPI and 10 cyamlnc the €ffecti of HSFI lose of fiDction on the respotrso to hwettrhermis. and cisplatl -besed chemotherapy in HeLe cetvicol carciÌroms-Ws lrave ldondffed the 322-nucleotids to g,1{}_ nucleotide HSFI geqúenco ae an ldeel taÌget for siRNAmedialed HSII sllcncing, have creatod a pSUPÉR-HSFt vector abl€ to potently suppress thc lltÌl gene, aùd lrave goneroted for the frrst flme human c€ncer cell linee with Étatf€ loss of HSFI hmction. We loport thot, att$ough lt surprtsingly does not eflect concer cell sendidvity to cidpletiù or elevatcd l€mperatuaes up to 43oC !v[€n adminlstored sepora,tely, loss of HSFI funcfion caudos a dtornatic increaee in senritivity to h)?crlhermochomolherapy, Ieadlng to massive (>95*o) apo-Lrtosis of csncer cells. Theee ffndínge indicate thot dierupdon of HSFI-lnduced cytoprotection duing blperlhermocb;mo-ther&py may rep+sent a po$erful etretsgy to selecdvely ampnry fhe damage in c&ncer cells and ldentify HSFI sr a promlstng thoropeutic target ln cervictl caiclnomo. (Cancer Res 2006; 66(15): 7678-85) Cancer Res 2006i 66i (15). August 1, 2006 7678 wÌvw.aacfjournals.olg
Intfoduclion
The heat shock rcsponse (HSR) io a fundamenfql ceÌlular dofense lnechenism against the cleletuúous efrects of physiologic arld envi_ lonmenta.l ltresses, which ptovoke cell damage due to protein misfoldin& degradotion, and insoluble aggegarion (1), Ihe HSR is regulated by a family of banscription faators known as heat shock îactors (HSl'; l€f 2). Among tlÌree trnctionally different HSFS in hunìarris, HSF t11le 1 (HSFI) ùediat€s signaling of stress-inciqce.i . n€quc8& for réprints: \,1 GabriclÀ Ss ntoro. Detù.tmor ot BFlogy, UniveBiryof Ro,rcTorVerg"rù Mr deUù turarm SciFnHtc4 00tj3 Rorne, tLdv. ph;ne 3$06-7159 4822: Ià: 39. sDtoro@bio, u njrcfrqr, i | , @2m6 Ameli.rn Aseoci!ùion for Cùncèr ResFr.L doi:r0-U58/m03-5.472CAì,t-05.428? stimltl such ar elevat€d temperatqres, HSFI is geÍelally fÒund in the cy'toplasm as aiì inelt ùo4orner lacldng hanscripbional activlty both DNA-bínding anrl trqngcriptional transactivation do-main8 ate repressed throùgh inhanolecular iùteractions and cons_ tilutive sedne phosphorylation (3). On e),?osure to heat shock and other typos of stless, HSF1 DNA-bi[diag activíty ís delepressèd. Subsequently, monomers oligomelize to a trimeric sÍate and form stxess-ind[ced inhanucleai gmrules, become phosphory]ated at sedne re6idúes, and trind to heaf shock elements (HSE) iocateri upsfueam of heaf shock-lespoÌtsive genes, switching on s essinduced transcdption (4), Heat shock gene promoters that contain HSf"e include the molecular chaperones of the heat shock Fotein (HSP) famjties HSP?0 and HSP90, of HSP2Z. and oLher proloins o[ lhe nehvork. HSF-binding siles arc also present in Lhe prorrÌoLers of the supercxide dismutase aod the trìultifuug resistarc; geoes (5, 6), HSP expresslon is tightly controlled in normal human cells, wherear it is oflen dlsregtlafed in tuhor celis. Abefiant exDression ol HSP90, HSP70, aùd HSf2? eit}ìer individuaìly or in "o^binulion has been wjdely reported ir human mnlignani tumors of various origins (?-9) and hae beon lhtked to cancet resistance to aDoútosis induced b1 chemotherapy and radialion lllerapy (101, On t;e other han4 h}?eÉhermia is one of lihe mijalalities used ill the clinical settÍng to fueat various lollns ofúalignancies aÌrd ha$ boen proven to be ospecially effeatir€ in cgmt ination wíth radiotherapy and. chemo_ dÈnpy in dnbrent mes of cancel including ca.rcjnoma of the uterine ceryl( (1L I2). For cetvical carcinom4 local h1?erthermia has been successfu.lly used in combination with systemic admi0ì$hation ufcispiatin-bssed chemotherapy in phase l,4i clinjcal sludies (13).
Because of d1e substantial technical impmvements recently achieved (l ì ), the clinical application of heal as a coadjuvant in carcer hestmenf is gaining netg intetest, Howevet one of Lhe main complications associated with the use of h)lletthetlDja i1 caneer treainent is the induction of the cellu.lar gtress lesponee, wlich prevents iÍeversible inactivation of proteins a.lrd biocks apoptotic eignaling, enhancing cell suryival (tO t4-l7). Therefote, sllateRi€s that inhìbit Lhe HSR would be useful lo sensitize c8ncer cell; lo therapies that use hlpeúhermja as a modality of treatme4l HSFI, being the main HSR regulatoÌ, seems to b€ a desirabl€ taryet to inhibit the sLre8s respon_se in concfi cells. By using sma]l interfering RNA (siBNA)-Eediated sllencing, we attehpted to obtain a HSpt loss-of-limction phenotl?e in HeLe ceffical carcinoma to examine the eff€ct ofHSFl silencing on the tespoffo to hyperthemía and cisplatin-bq.sed chemothempy. HeÉin, wo tepott that loss of HSFI lunctio!, altioùgh it surpisingly does rot affect cancer celi sensitivity to cisplatin cbemothenpy or to elevated temperatu&s whet administer€d sepalatoh rcsults in a drama c inclease in BensítMty to apoptosig induced by cytostatlc doses of cisplatin associated with ht?etthermia.
Materlals and Methods
C€Il cnlturc, treatmente, súd hansfeefioùs. HeLa cells lAnericm Tvpp Cujtul? Col,ecuon, Manss6as. V]1) were growlì ot 37oC in a S% CO) abllospherc in DMEN4 supplemenred wirh l0FCS,2 rnmoli L gturainirìe, end antibtotics Oìfe T€chnologies, lnc., pajsley, Scotlaîd), H€La celts stablv hEiìsfecled wjrh pSUpEt/pcJN43 and pStrpER-HSFti werF majntsincd j;
?MtrM sup_plement€d with 109ó ìrCS ín rlle presence of G41B (400 Fg/mL), Cell Ìlalrllity was detennjned by dle 3"(45-dimerhyltht!lzol-2-i)_Zgdiphenyltetrazoliuft brcmide (MTT) tjo MTT folmazon conversion ossav (Sigmu.Aldrlch, St. Louh, MOJ. Por MT,t assay, reduLed M fT ttornì.lzar,) r€s erLracled from ceus by adding t00 pL actdic '$propanot cont ning l0% Triton X-100, Alld formqzqn absorbance was measured in arì f,LtSA m;cloplabe ÉtdeÌ ar rwo diffe&nt navalengths (540 ard 690 nm), Clsptatin ldir-dialnmineplatinum(11) dicltoride, Signa Cheftical Co., Sr. Louis, MOI w.rs d bsolved in 0.9tt Na Cl im medicbty before use. For h eatil rg pro ced ru es, cells $-ere kcpt at diflorenr tempef&r&rss (rangirlg &où 41.C r; 4S'C) in an irlcubator in d 5% C02 afmosphere FoÌ combirÌed tr€ lncnrs, hwertfiermiî \^,aÉ adminislereJ 2 hours affer expoEu-ce to cjsplafin to mjni; nreviously rlpofted clinical settirg conditlons (lg), A1l trÀrufectjons wBrc done ùslne LipofcctAMlNP Plus rcagent {hvíf,ogen, Carf6bad. CAI arcora;ng Lo rhe maÌrùî!4turer's ptutocols.
,
V€€tot cortstlùctlon. The proc€dfire for pr€paring constÌucts coding for sinNA was descúb€d previousty (18). Among difi,erenr HSFI rarye; serìuences e{afiinpd. úìe t+n0cleoudo genesppcjîc "nqu"n"" "p-n:"g Ílom nucleotídes 322 to 340 do llsheam of rhe gene transcr:prion starl site nar selected to suppress HSFI gene eJ.?ressjon. After RLAST anah€is, to eusúe l.hut ther€ was no sign;ficanl sequence homologv with other húnan genes, the selected sequence was jnserted into É BgllllÈtrÈdlll_cut pSUpRR vector to generate ,he pSUPER-HSFIi vector. The psl?rpnR_Ds3i v€ctox was gpnemted as describcd abote using rhe sequence rcporteà in ref 18. I'he pSUpER-cFPi vector was a glft fton1 Dr, Antoùio Co6tànzo (Unive$il1, of Romc Tor Vsrgatos nomc. ttalyt, EFjtop€ Flag.tagged ltsp27 lector 6as ; giÍÌ from Dr. Ky[-Jin Paft (Univer€iby of Texas, Southwest€rn Medicrl Cente!ì Dollàs, TX), The pH2,s/hsp70 and pÀtNt-3/hspg0 vecrors were kindly proyidcd by Dr, tuclìard L Morimoto lNortlìweEtem Unj!€rsjry. [vansrori. IL). To generqte lhe Flag-tagged hsp7o,pcDNA3 vecror, the hùmarì 1lspzo gene was, amdiffed fom rha pH2.3Aì6p20 vecror using lhe foltowjng pl'inlellj 5-GcCGGATCCACCATGGCCA,AAGCCeCGcCACTC-I ltnd s,_TG CGGTCOACCTACTTATCGTCGTCATCCTTGTAÀTCÀTCTACCTCCT-CAATGGTGGG-3', The PCn pro(luct wa.s digestect wíth BarrHl and &Ín and inser'l€d into a tdmltlls4t1drt pcDNAi vectot. For conshîction of tÌte Flag-.Lagged lNpgo/pcDNA3 vecror, rhe human Hgpn eene \ras ampliffed &om the pKl\ r.3/hsp90 vaclor using rfe fcrltowilg primers: 5 -TTTGCTA(ìCCCTGACGAAGI ccACG3' and s'-A ACTCGT{GC IAATCG ACTTCITCCATG-Í. The pCR prcdud was digeEted with -tùt?t and "t al and inso ad jn f]to,úte h\to a Ma1./Ìúal-cut pcDNA3 vector contajning lhe Flag-tagged sequen(e at thp COOH term;nus. AÌl constnLts wcre con, ffrhed by DNA sequence anallsís.
Geref?tlod of stable HsFl-slten(éd ltì€s. To obtaiú HeLa cell line! stàbly exple6sing 6tRNAs, thè pSUpER or pSUPDR-HSB1i vectors wete cotrànsfocted ì,yith tùa pcDNAg vector, ond stable integla4ts w€re select€d by ùsing c4l8 (1mg/ÍLl,) staring 72 hoùrc alter ha.n$f€crion, Alter IS dalE in selective medlunì, two pools, referrcd as Hel,a-pSUpER-p a.nd HeLe, HSFIi-p, were isolated. The HeLa-HSFli-p was subj€cted rp lblrher cloninq procedulas by tlc limjting dilution meúod. Aff.e! 2 monlhs, rhree clone! pìrsenting a >95% rèductlon jn HSFI protein levels compared,\.lt} control (HeLù-HSFli olones 3, 16 rnd 31) were isolàtad. All stable call tines obrained wera cultùred in DMEM supplemented wjth &18 (400 trg/inl). The C4t8 selsctive preosure was rernoved 24. ìroÍrs befote expedmental Droceilurcs.
Confocal Elcroscopt, Cells grosî on coverslips werc ft{ed w h 4% palalomaldehyde ànd perm€ùbilired in 0.1% Trlron X-100-PBS fo! 10 miÍut€s. AItér itocking witù 0,2% bovine 6erom alburrin, celk were lncllbuted witi lat anti-HSFI morodonal antibody (Shessgen Biotechno! ogi€s, Víctori4 British Columbiq Canada) folowed by decoràrion wúh fluorcscejn'conjúgated anti-rat IgG, tnages w€re acqLúred on a l,eica confocsl microscope (TCS 4D sy6ten, 100x objectivq Leic4 Nwsloch, Germany).
Electmphor€dc
mobiltty shtft assoy, Whole-oeìI exhacts (15 !€ protpin) prep$€d cfier l]îis ln high-sair erlrecHon bufer (t9) w€re incu_ batpd with a yplobpled HSE DNA probe followed by rn.ìtysjs of DÀA_ binding activjty by eiectrophoretic ntobifry shíft alsay ([MSA). Binding îeàctions w€re done aE desùribed (20), Complexes were analyzed by nonde" lraturing 496 PAGE. Quontltativo evatuation of HSF-HSE comDlcx îorma, tjon \rrs determinpd by Twhoon U600 tnlager wjth the use ofimageQuanr. (Moleculat D!'namics, Alnelsham phafinrÌI,iù Biotech ptscataway, liJ). _ We8tem lrlot aÍallde, Equat amouDts of prorejn (gS tg/6ample) trom whole-cell exhacts werc separùted by SDS-PAGL qnd blott€d to nitroce! luloee, A.Íter blockirg nith S% sktm mijk solution, membranes we& jncubated with mbbir polyclon{t arìti-IISFI, $nri_I.ISFt odndly prcvjded by Dr. Richard L Morimoto), anrt-poMADp-ribo$e) pol),fnelase (pARl}), ùti p66 aìtj-HSPg0, snd aDtl-ESp27 antjbodies (Sanra Cmz Biot0cÌìrologJ,, Siùrtr Cnlr, CA) or monoclorul ànti-Hsp70 inducible isofomr (SaessgÀ Bioteclùologies) and aDri-Èactin (Sigma) artíbodios followed by decora_ tion with peÌoxidaselabeled md-Ébbit or anti,mouse lgc Espectively (Sùp6l Signal detecfion kft, pierce, Rockford,IL), euandtariw evatùarion oi prctejn$ r.r'lls detemined by VùsaDoc 1000 aialysis ustng ihe euntity CJne soltwùe pro$am (Bio-furd Laboratories, Hercules, CA).
RNA atraly8ts. RNA ftom HeLa cells tra.rìsientjlv tren6fecteal rritlt pSUPER HSFIj or fiom HeLtsHSFli ctones was e\:ù-aI.rpd as dor.rJbcd prwioosly (2O. RNA (3,0 $g) was loaded on ù 1116 denatffing polyacry! ùnide gel snd_separated and blotted a.s d€scdbed (22). Membra es were probed witi a shJabeled ssnse tg-mrcleotide HSFÌ larger ollgonucleofide aùd visualjzed by phosplìodmrger. d-Fluore3cein-.labeleal oljgos were seil Aralysis oî cell cycle and apoptodtÉ. For cel cycle sudies, H{,.La_ pSUpER"p and HeL&-HSFI cells were tryp6jnized elìd 1ixed for 45 minures in 709ó ics-cold ethanoL After rspeated washings, cells werc steiúed with a solution containing 100 t.g/ml RNuse A end 40 pg/Íúpropidium iodide îor 30 minubes at rcom teÌnp€mture aod ana4zed on a IACScan (Becton Dickin6on Lab&:ar?, Mou taiì Vlew, CA) witù laser excitatr.on a[ 4Bg nm. The percentsge of cells in eaeh stage of the ce cycle was detemined ùsirìs CelÌQupst soft&arc {Be(ton Dluhnson Lan\ ore). For DNA ,tatrinA cplts wera Gxed v!ìttì mallurol ùnrl incubaled v!,ldr 5 lg/rnl 4,,Gdi;dino. Lphenylindole (DAI'I) for Bt minùres in the dartr !.lostinq cells were also bred and rel.uned to the tcspe,.tive wrl!. Cclls ì,ere analyzed using an Ob.rnpud microscope (OlymÈus CorpoEtion, lblryo, Japan) ar 4m nùL Cells exlúbiting morphologic features of apoptîsis, jnc.luding chromatin eondensation ard nucleal. togmentation, wele ooúnted ln six to eight randonly celected ffelds (23), Approximqtely 500 nuclej werc eJtaùined lor eaÉh sarìple, The rasuits are sxpr€ssed a5 llìe number of apoptotic nuclei over the tot4l numbe. o, nuclei cormted.
Besults
Selecdve inhlbluor of HSFI gcno cxpression by siRNA-m€di&ted silenci{g. To suppress HSFI gene exprcssion jn HeL! cell6, we fil6t identiffed a lg-rucleotide gene-specific seq[encè 6panníng trom 322 Ia 340 downsheaùr of trhe gene frènscríption sttut site and tàen generutod a pSllPER v€ctor o,pessing a speciiìc siRNA targetlng this Bequence in tbe f/gFj gone (pSUpEl-HSF1ù. Subconlluent HeLa cells worc either mock transfected ot tlansîected with empty pSUpE& pSUpER encoding gIRNA agairsi gr.een fluolescent protein (GFpi pSUPÉR-cFpi), pSUpER encoding siRNA against p53 (pSUPER-p53i), or pSU?ER HSIrli vecrors, After 72 hours, HSIì1 protein lelels wèle detemined in whole-cell erfracts of transfecLed cells by Wertem blot a.nalysis, As sho1rn ín Fig. 1,4 Flgure l silencing ol HsFl bv irsnsi€nl and stablè iranslection in H€Lacetfs.,, HeLa c€JIs were tansfècted with thé indicaled psupER-RNAr vecìors. rop, aner 72 hourc' HsFl levÉls were d€termlnod bvwesem olot ànarys;s iriví;ì;ói;;;"i;; r"ck fansferted c€rb (corlro, i'a,,e T) or cels rranslocted wirh emptv psuPEF (psuPFR /ane 2r' osuPER;codins .tnNe "g"in$ crÉ óérÈÈÀiàlÉi tii'_g_1rqsu155 9*9ci1s siRNA asainsr dss {psupER -ps3i, rane 4). or psuPER encodng siR\A againsi HsF (psuPgR+fsFt; r"rà sl "lir":"'*orri"À, Li"i""oiijlr",.n "o" o",emined in rh€ same sampbs;s roadng conl.or. r,. Èr6La ce s were corransrected wirh D.DNA3 and €ilher lhe empi psupÉR or tnó péùÉÈàInsrrr vecto;"il;i;; ffiilRft;5,!àrlJ,uo oy u",ns G'418 (see Malerials end l\,lethods io' belailsì. rop-, HsFl teveJs ;;; de#i"àj l"v"ùi"à"', tr"r.-aysis in whot€-cel exlracls from poots ot H€La-psupER @supEn-p ldnes |.3, atld 5) and HeLa-HsFìi (diF u"p. t"i"ii, q-. inA-èi àìili iír.làiiìmj iampres ai roaoing ;;ói vú""ù,"
-rìJt "i'àryl,i" ", on€ representative expedm"n, o, *r"" **n",Í$1t$illj,|boíì,m, tevers of g-?ctin were d€tehineà in rhe same pSUpÉR-HSFli vectorsj aftsr ?2 hours, stable inteqmntr !ve!e selectrd by using G418. Aft.er t5 days in selective mellium, rosiol_ ant pools of psLTPER/pcDNA3-cohansfected (HeLa.ìpSUpER-p) and psuPER-HsFti/pcDNA3-cotransfecred (HeLa-HSIli_p) cells were obfained, HSFI levels in HeLa-pSLrpER-p and HeLa^HSFJi_p pools wote anallzed by W€otern blotting ot 24, 4& and 22 hoqrs afíer plating ::d__quantifieg by densirometlic analysis. A,e shown in nig. fBì HSF1 proteiù levels in HeLa-HSFli? cells were rectrced by l?0% compa.r€d with HoLa-pSLDER-p cells at all times î€sted. The fact that lisFl ptofein levels were kept rema.rkably low dùing cell growth for at least 72 hour6 indicates tbat siRNA_mediated -HSF1 sfencing is not influenced by Òell cycling in {tis úodel. Isolatlon and chatactorizafion of HeLa clones wlth stoble loss of HSFI funcfion. As descúbed above, HSFI levels ate substafttia.lly reduced in HeLa-HSFli-p colls; however, as teported for sev€ra.l olher siIlNA targets, HSFI inhibition obtained b; RNA hfÍ"I:r* (RNAi) is nol complete, In lhe anempr to generate Etable HeLe phenot'?es with loss of HSF1 function, H6La,HSI]ti-D cell6 were subiected Lo cloning proceduÌes by t.he limiting dilution m€thod. Aft4l 2 months, 60 clones were isoÌated and analyzed by Westeh blot fot HSll protein levels, HSII reduction v8.ried ftom 50% to >95% in diffetent clon€s (clata not sho{,î), probably reflecting diffe.ences in the number of pSIIpÈR_HSF1 cooies intsgmt€d and/or differences in ù€ integmtion sites, At the enà of selecliorL lhree clones presenLing >9S% reduction in HSFI le\els (HeLa-pSUPER-HSF1i clones g, 16, and 3I) were chq$en for lorLher chaJacî€Ìization.
HeLa:pSLTPER-p cells aIld HeLa-HS!fi ciones were eubiectod to heat shock at 43'C for I hour, and whoje-cell ex.Lracts were aralyzed lor HSFI artivation b,y EMSA and for HSF1 protein levels by Weslem blot. As shown in F:g. ZA ltop), HSFI aclivation was detected after heat shock in tIeLa-pSt/pER-p cells but rlot in HeLa_ HSFIi clones, Accordlng to the gel retardetion analyqis rcBults, botb HSF1 protoin (78 l(Da) and it6 phosphorylatred îorm (90 kDa, norma]ly fomd aííer heat 6hock) were detected in EeLa_pSlJpÈR-D cells but noL in any ofthe HeLa HSFIi clonec tanti-HS.Fi; tig.2.4i. Díflerentiy iiom HS!l, lovels of the HSFa the p6E subunit ;f the txansadption factor nuclear îactor-KB (M-KB) ard B_actir were similar in HeLa-pSUPÉR-p cells and Hela_Hslì1i clones, confuÌrins a seleclive siJencing, of HSFI, lnte!€stingly a teduction in HSFz ptoteln levele was obreryed in HeLa-HSIIi clones after heat shock It ha,s lleen rcported thaL during heat shock, HSF2 undergoss reversible inacHvalion a$sociat€d with ihe convetsion ftoh a soluble to an aggregsted form (24). The lower leveis ofHSF2 obeeryed in HeLa-HSfii Jonee suggeet the possibility that HgF2 may be more thermolabile in the absence of HSPI and/or in conditions of a defective HSR In parallel experimenk, HeLa-pSUpER-p ceìÌs and. HeLa_HSFti clones gtowing on coverslips were sobjected to heat shock at 43'C for I hour and aralyzed for hoat shock-depende4t charges in HS_FI intraceuular localizal,ion by confocal microscopy usLg anti-HsFl ariribodies. ,As sholrn in Fig.28 , otr exposure to heal shoclr HSFI reìocalizes to form brightly stained nuclear foci in HeLs.-pSLTER-p cells (2S). HSF1 granules were nor detected in HeLa-pSUPER-HSFI ctoîes ($* ,lefr) Finally, the explession of HsFl-spscific siRNA was deteEiined in all clon€s. lbtal RNAs extracted ílolo HeLa,pSÚpER p, H€La_HSF1i, or HeI-a cells hansiently traùofected with the empty pSUpER ot pSltPBR-HSFli vectors were analyzed for HsFl-speciflc siRNA expt€ssion by NoÉh€rn biot, Blots wère probed with a 3?p_labelèd. sense l9-nucleotíde HSF1 probe corresponding to the targeting s€qfrence ar|d visualized by phosphortnager. As shown in fu, 2e in HeLa cells transiently transfected witl.ì the DSUPEILHSF ti v;ctoî. bolh the stsm loop precursors and the siRNAs were deteclcd, ln all HeLa-HSFli clones testod only fhe HsFt-speciffc siH\lA was visuaiized. HSFI siRNA was still delecLed in HeLa,HSFti clones after 6 modths in culture.
olRlIA-mediatod HSFI s enclng is not djîocled by h)Irer_ theùÌic treetmont As indicated above, loockdown of HSFI fmction did not cause major alteraHons in HÉLa c€ll proliferation and ùorphology und€r noruìal growth condirions, ln addit_ion, no signifrcant diffelenceE in cell sonsitlvity to mild heat shock conditions (up to 43'C for t horú) were detected (data rot sho\,!îr). TIle iemperaltlle of 43'C for I hour was then selected as a slandatd h'?e herynic heatmeÌrt condition. Because littls is I(nówn on LIle elfecli ol temper.atue on síRNA_meclial.ed gene silencing in mammdian cells, we next examined the effecì of hl?efther'úic treatment orì HSIìI silencing in Hst a_HSFli cÌones. l{el,a-psupER-p and HeLa-}lSIrt j cells w(]re èither kept at 3T.C or Fubjecl.ed to h)?ertrÌìermic tl?atrnenl ànd 1en alìolrecl Lo lecover at 37'C. At different Limes cluring fìre recovery pedod, whole-cell extracfs were analyze.l for HSII DNA-bntding activity by EMSA and for HSII, HSP90. HSI)20, and HSP2Z prolein levels by Westetn blot. As (lxpected, in Hel,a-psupglì1 cells, Hslil activaLion wrs delected at tlìe eùd of the heal shock periorl and contiùued fof 1.5 hours at 37"C, aft.er which Lime it declinecl rapiclly (I,,ig, 3, lnp) . The slow-rnigrating phosphorylaled HSII form lvas also detecfed at fhe time ofHS! activalion. LlSIrl activatiotì was rapidly followed by sustained USP90, HSP70, and rISp2Z synrhesis (tìiB 3), Dif_ lèrently from Hel.,a-psupÈ,1ì? cells, neither HSIfI acLivùtion nor HSp synl.lìesis was deteclecl at any time in HeLa_HSFIí clone$ (Fig, 3) HSFI genc sile clng doe3 not alter flc|,a cell gonsitivitv to clsplslin.'lo dcterminr thc ettecl of HSI I srlnncinq rrn canc.r (cìl .ensiLj\ify to rhcmotlrerap). HeL H:t.li rlnncs.l]ìd Hvt..r pStJPEIì-p cells were plated (ll x 105 per weli) in culf-rlrc medium containjng 5% lìCS and Lrcated with dift'èfent coll(ìenlrations of cisplatii. Alter 2,tr houÌ.s, rytotoxicitjy and the petcentige of apoprolic cells weré determined by Mî'f' assay and DAll staj infL resplcl.ivcl). ln bollr t.)l)es uf ccllî, c,spl.rtin a{ corrrpnfrarions ol. 40 to 100 pmol/ì, induced massive (-t00%) apoptosjs, u,hereas it lrad nn effp, t at lhe (oncenl'urior).t rO lrmol,i (frg.,^Iì. tu.i( o1 toxiciÍy of cisplatin &t lhe concenLroLioî of l0 pnÌol/I, wss confirmed in both types of cells by MT"l assay (data nd shown). ID paraìlel experiùìents, the effecf of l0 Imol/L cisplalin on celÌ rvtlp ptogÌcssion rlns detÉrminùd l,y tl ores, en, e-a,Jivale(l cerl sorting (FACS) anrìly$is of cell cycie phase dist.ribution aller propidium iodide staiùing at 24 and 4g houÌs altet trcalmenl As shonaì in ltrg, 4B (t)op), HeLa-pSUpER-p cells and t{ef.a FISF.ìi clones showed idenLicaì celì cycle phase distribution prolliles. ra,ith hz.:l.r ofl.cllò bcinp, iî cr cr.8..t,,. in c? i\t.,rnd t9,:t9,. in S Dh4s!,. Al 24 hoor\ ufter ctsfltttin treatmént. hnth tlpc. ot rells r,î.!rmul. ated in S pbase (-8996), wheress .3% cells 1,r,ere îound jn 0)_M rnd no celis \rÉrp detectpd in Gù Cr. At 48 hours atjer rreatrnent, -90ùlo of cells accrlrlnrlated in GrM, wh€reas 9.g% Ìvere l.oun.l jn Cdncer Resèarch the S phase and ncr cells were detecled jn Co,Gr in both Lvpes of polìulcli,,ns ttig. 48. biunnt. Ilrpse rpsults inri;carp thri ftst I siÌencing did not alter the r.esponse of Hel,a cells to lolv-dose cjsplatin treatment, llhe lo,;Lmolft concent.ration of cisplatin wa.s tllen selectied fot frlltl]er studies. HSFI genc ailencing sen8itizeli HeLa cells to cornbired hi?erthermia/cisplotin ttealmcrrt. We next anaiyzecl the e{fect oî HSFÍ siiencing in cells expos€d to cornbinecl hyperllrermìa/ cisplatin lrealmenr undpr.condjtions in \rh,ch erù,h tieatmcnl wa" inellectiye in inducjng apoptosis in both Ìlel.a_psulEll_D and llcLa HSlrli cells nhpn admirìrsrerecl separ,rtel;. Het.a HSI li i.lones înd Hcl d pSUl)LH l) .ells wprc rlcrr"tl rnirlr l0 xrol/t_ cisplatin ond, olter 2lÌo,rr,ì, sulriecled lo ìì\.perthermi. trnrlmeni. Aî,er 24 hoùs, cells w€re anallzed by Vt/estern blot for I,ARI) cleavage as a biocìtemical marher oI aPoptosis, fot HSp70 levei as an indicator of HSIì ùctivat.ion, and fot fì-actjn a^\ Ìoading control. observed in HeLa-HSlìli clones corùpared with HeLa-pSUpìÀ,r) cells wlren ltyletfhprmia and ( icpl.rtrn rrertmcrrts were athninis te,€d separalely, Inl.erestingly, opposile resulls were detected rvhen cells were exposed to combined hypefihermia/cispìatin treatment, In làct, under these conditjons, whercas HeLa-pSUpIiR p cells did not responcl -95% of HeLa-HSfL_ cells ulder.went apoDtosis anal die(l ,'l 24 lìoLUs aflcr Irpàlmerìt {Fit. il drìd rJ..t,J.xclude rlìe possibilily tirat Hela-llslrti cell sensitivity to apoptosis wa.s due to clonaÌ djfferences, Hela-Hsfli-p celÌs were treaÍed identÌcallv and.rnalyzed as dpqcribpd iur Hcl.î H\l lt ,lo es. Alttrouslr les" pronounced, similar effects were del.ect€d in HeLa-HSÌ|li-D cells: indu.lion of apopl,,<is wÍLs obj,eÌveLJ in >So.i nl. Coexpression of tlre nrajor HSpq), HSPZ0, and HSp2? HSps pertially reverts sensitlvity to hyperthernria/cisplafin_induced flpoplosis in ltel a HSÍti r.loner. to verit\ rvhetlier tlrc actr"ured sen\if ivity to l')p.Ílìtsrmja.cisplJtin inrjrrced apoprosis olrservecl in Hpl..FHSl lr c,oner wos due tu arì inrfarrrnen{ in HSI) c\trreq.ion, Hcl d.HSlrl cell" t\er|, transfecFd uirlì re rrnptv JCDNA3 vpct(,r olwith pcDNA:J vectors expressing the Ilag,Lagg€d fornìs of HSP90, I-ISP70, and Sp2Z eiLher individuaily or in combination. A1 16 llours alìer ttansfectioll, cell$ were trcatecl witlì 10 umol/t, cispJalin c ,l. i.ller 2 hours, subje|ted rn hJpeftlìprmrc treatmcrìt. At 24 hours aller lleatmenl cells welf) analyzed for pAll! cleavage and for levels oflrlag-tagged HSP9O, HSpZ0, anrl HSp27 ancl ll,acdn by W€stern blot, Levels of lAÌlp cÌeavage were qlrantified by VersàDoc 1000 using Quartity One soflware. ^s expected, h1per, thermia/cispìètir cotr,ealment restllted in complete IAII) cÌe;;age (Iig.6,1). As shown in Fig.6n , altho.€h 1ìGligÌrlrrevorsion in pAlìl) cleavage ll,as observecl when HeLs-HSFli cel]s !r,eÌ€ lransfècted witù HSI27, HSP70, aad HspgtÌ separaf.ely {10% lÌ)r HSI2Z and HSP90 and 18% for l-ISp7O), a relevant elfeci ivas obtained onlv when Jll fhrpp H)1,: rer'e r oexl,rescpd (foùa rpduch,,n in pq.Rjl cleavage cofnpated wilh Hel,a HSfli cells LÈÌìslected witlì llle emDtv verlon T:ig. M anLl /iì. Consideri g lhat the rransfertion elfi,.ic;c/ rf tjrese cells t{as -709,i. tlìis,?cult sepm. to bc $eatly srgnifir ant. 
llel.a-HSF1i

Discussion
Oatcinoma oI te t1teÌiùe ceùix is ìe second n1osl cornùon Îernale cancer woridwíde (26) . Improvemenls in f.he eatly clelection of cervical cancers have substantially reriucecl the aelrorriat€d morlrìlitl' rales over llle pa-st decades: however, in patients diag_ ix'sed \ti,h advrn( Ld rrervicdl cani"rrs. thp mortalitl rar"s Ir,ltr remained oùchanged over t.lrc past 25 yeàrs (22, 2B). C ùentlv. .rdvanr'eri rerucal rrncer is trcatpd witiì fa.liotlrcrsl)\ dIl r isplalirr hased chernotheralry: neveflheìpsi. untorf Iatel!, most patienls will eventually relapsq iùrd improved treabn€nt opti{}ÌÌs îoÌ Lhis ll?e ol matignancy are highly needed.
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